Q1 2022 · 13F-HR
Revelation Capital Management, LLCholdings as filed
Filed 2022-05-12 · accession 0000950123-22-005393
$27,351
Reported value
3
Positions
2022-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 82933R100 | — | SINGULAR GENOMICS SYSTEMS INC | $14,008 | 51.2% | 2,219,951 | Common | SOLE |
| 90138Q108 | — | 23ANDME HOLDING CO | $10,217 | 37.4% | 2,667,736 | Common | SOLE |
| 641288105 | NPCE | NEUROPACE INC | $3,126 | 11.4% | 380,705 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.